These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 25915411

  • 1. Construction of a BALB/c-Nu Mouse Model of Invasive Bladder Carcinoma and Preliminary Studies on the Treatment of Bladder Tumors through Internal Iliac Arterial Infusion of Albumin-Bound Arsenic Trioxide (As2O3).
    Li Y, Yu G, Li Q, Wang W, Shen X, Liu H, Liu R.
    PLoS One; 2015; 10(4):e0124959. PubMed ID: 25915411
    [Abstract] [Full Text] [Related]

  • 2. Intratumoral injection of arsenic to enhance antitumor efficacy in human esophageal carcinoma cell xenografts.
    Shen ZY, Zhang Y, Chen JY, Chen MH, Shen J, Luo WH, Zeng Y.
    Oncol Rep; 2004 Jan; 11(1):155-9. PubMed ID: 14654919
    [Abstract] [Full Text] [Related]

  • 3. Preparation of arsenic trioxide-loaded albuminutes immuno-nanospheres and its specific killing effect on bladder cancer cell in vitro.
    Zhou J, Zeng FQ, Li C, Tong QS, Gao X, Xie SS, Yu LZ.
    Chin Med J (Engl); 2005 Jan 05; 118(1):50-5. PubMed ID: 15642226
    [Abstract] [Full Text] [Related]

  • 4. [Primary study of arsenic trioxide inhibits abdomino-metastatic tumor formation of human ovarian carcinoma in nude mice and its mechanisms].
    Huang SG, Kong BH, Yang RF, Jiang S.
    Ai Zheng; 2002 Apr 05; 21(4):401-4. PubMed ID: 12452020
    [Abstract] [Full Text] [Related]

  • 5. The inhibition of growth and angiogenesis in heterotransplanted esophageal carcinoma via intratumoral injection of arsenic trioxide.
    Shen ZY, Shen J, Chen MH, Wu XY, Wu MH, Zeng Y.
    Oncol Rep; 2003 Apr 05; 10(6):1869-74. PubMed ID: 14534710
    [Abstract] [Full Text] [Related]

  • 6. Arsenic trioxide (As2O3) sensitivity of carcinoma cell lines and cancer cells from patients with carcinomatosis peritonei.
    Moon Y, Park G, Kim Y, Kim M, Lim J, Pai SH, Lee EJ, Kang CS, Han K.
    Ann Clin Lab Sci; 2004 Apr 05; 34(3):271-6. PubMed ID: 15487701
    [Abstract] [Full Text] [Related]

  • 7. Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models.
    Hines-Peralta A, Sukhatme V, Regan M, Signoretti S, Liu ZJ, Goldberg SN.
    Radiology; 2006 Jul 05; 240(1):82-9. PubMed ID: 16720872
    [Abstract] [Full Text] [Related]

  • 8. Synergic effect of 3'-azido-3'-deoxythymidine and arsenic trioxide in suppressing hepatoma cells.
    Chen C, Zhang Y, Wang Y, Huang D, Xi Y, Qi Y.
    Anticancer Drugs; 2011 Jun 05; 22(5):435-43. PubMed ID: 21502917
    [Abstract] [Full Text] [Related]

  • 9. [Arsenic trioxide induces differentiation of human nasopharyngeal carcinoma in BALB/C nude mice xenograft model].
    Du CW, Li DR, Lin YC, Wu MY.
    Ai Zheng; 2003 Jan 05; 22(1):21-5. PubMed ID: 12561430
    [Abstract] [Full Text] [Related]

  • 10. Arsenic trioxide inhibits lung metastasis of mouse colon cancer via reducing the infiltration of regulatory T cells.
    Wang L, Hu X, Xu Y, Liu Z.
    Tumour Biol; 2016 Nov 05; 37(11):15165-15173. PubMed ID: 27677289
    [Abstract] [Full Text] [Related]

  • 11. Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice.
    Liu B, Pan S, Dong X, Qiao H, Jiang H, Krissansen GW, Sun X.
    Cancer Sci; 2006 Jul 05; 97(7):675-81. PubMed ID: 16827809
    [Abstract] [Full Text] [Related]

  • 12. Antitumor effect and mechanisms of arsenic trioxide on subcutaneously implanted human gastric cancer in nude mice.
    Wu DD, Xiao YF, Geng Y, Hou J.
    Cancer Genet Cytogenet; 2010 Apr 15; 198(2):90-6. PubMed ID: 20362223
    [Abstract] [Full Text] [Related]

  • 13. Anticancer effect of arsenic trioxide on cholangiocarcinoma: in vitro experiments and in vivo xenograft mouse model.
    Kim EY, Lee SS, Shin JH, Kim SH, Shin DH, Baek SY.
    Clin Exp Med; 2014 May 15; 14(2):215-24. PubMed ID: 23467906
    [Abstract] [Full Text] [Related]

  • 14. Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.
    Yang W, Ge J, Liu H, Zhao K, Liu X, Qu X, Li W, Huang Y, Sun A, Zou Y.
    Cardiovasc Res; 2006 Dec 01; 72(3):483-93. PubMed ID: 17020754
    [Abstract] [Full Text] [Related]

  • 15. Arsenic trioxide re-sensitizes ERα-negative breast cancer cells to endocrine therapy by restoring ERα expression in vitro and in vivo.
    Zhang W, Wang L, Fan Q, Wu X, Wang F, Wang R, Ma Z, Yang J, Lu SH.
    Oncol Rep; 2011 Sep 01; 26(3):621-8. PubMed ID: 21687957
    [Abstract] [Full Text] [Related]

  • 16. [Anti-angiogenesis effect of arsenic trioxide plus cinobufacin on human hepatocarcinoma transplantation model nude mice].
    Liu L, Chen BA, Qin SK.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Jan 01; 31(1):67-72. PubMed ID: 21434348
    [Abstract] [Full Text] [Related]

  • 17. Effects of Tat peptide on intracellular delivery of arsenic trioxide albumin microspheres.
    Zhou J, Wang QH, Liu JH, Wan YB.
    Anticancer Drugs; 2012 Mar 01; 23(3):303-12. PubMed ID: 22123336
    [Abstract] [Full Text] [Related]

  • 18. [Inhibitory effect of arsenic trioxide combined with cisplatin on human nasopharyngeal carcinoma xenograft and DAPK in nude mice].
    Huang X, Wang X, Hu J, Zhou H, Zhou K, Zhang Y.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 May 01; 27(9):479-83. PubMed ID: 23898615
    [Abstract] [Full Text] [Related]

  • 19. Cytotoxicity of arsenic trioxide to transitional carcinoma cells.
    Pu YS, Hour TC, Chen J, Huang CY, Guan JY, Lu SH.
    Urology; 2002 Aug 01; 60(2):346-50. PubMed ID: 12137851
    [Abstract] [Full Text] [Related]

  • 20. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
    Maeda H, Hori S, Nishitoh H, Ichijo H, Ogawa O, Kakehi Y, Kakizuka A.
    Cancer Res; 2001 Jul 15; 61(14):5432-40. PubMed ID: 11454688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.